FutureMeds Teesside - Middlefield Centre

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Chronic kidney disease2 trials
• Obesity2 trials
• Type 2 diabetes2 trials
• Coronary artery disease1 trial
• Heart failure1 trial
• Peripheral artery disease1 trial
• Stroke1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Active, not recruiting1 trial
• Completed1 trial

Lead sponsor

• Eli Lilly and Company2 trials

Running trials

• Active, not recruiting

  The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

  NCT06383390· Phase 3· Eli Lilly and Company· Source

Closed trials

• Completed

  A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes

  NCT05936151· Phase 2· Eli Lilly and Company· Source